Bacteria Gene Gene Editing Reagent 
Drug Discovery World
JULY 18, 2023
Since its discovery in 2012, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionised the biomedicine and cell and gene therapy fields, providing a versatile tool for precise and efficient genome editing. Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g.,
The Pharma Data
DECEMBER 2, 2020
aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. The new “pathoblocker” treatment aims to disarm pathogens and suppress the disease-causing properties of P.
Expert insights. Personalized for you.
98 
Let's personalize your content